GT200600032A - Procesos y compuestos para la preparacion de derivados de naftilindol sustituidos - Google Patents

Procesos y compuestos para la preparacion de derivados de naftilindol sustituidos

Info

Publication number
GT200600032A
GT200600032A GT200600032A GT200600032A GT200600032A GT 200600032 A GT200600032 A GT 200600032A GT 200600032 A GT200600032 A GT 200600032A GT 200600032 A GT200600032 A GT 200600032A GT 200600032 A GT200600032 A GT 200600032A
Authority
GT
Guatemala
Prior art keywords
compounds
naftilindol
derivatives
substituted
processes
Prior art date
Application number
GT200600032A
Other languages
English (en)
Inventor
Xinxu Shi
Vladimir A Dragan
John Richard Potoski
Wayne G Mcmahon
Jean Louise Helom
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200600032A publication Critical patent/GT200600032A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A COMPUESTOS DE LA FÓRMULA GENERAL I EN LA QUE R1,R2,R3,R4,R5,R6, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SON INHIBIDORES DEL ACTIVADOR PLASMINÓGENO INHIBIDOR1 (PAI1) POR LO QUE ES DE UTILIDAD EN CUADROS DE ENFERMEDAD CORONARIA, FIBROSIS PULMONAR, TROMBOSIS. T2006
GT200600032A 2005-01-27 2006-01-26 Procesos y compuestos para la preparacion de derivados de naftilindol sustituidos GT200600032A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64761805P 2005-01-27 2005-01-27

Publications (1)

Publication Number Publication Date
GT200600032A true GT200600032A (es) 2006-11-14

Family

ID=36570379

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600032A GT200600032A (es) 2005-01-27 2006-01-26 Procesos y compuestos para la preparacion de derivados de naftilindol sustituidos

Country Status (21)

Country Link
US (2) US7323483B2 (es)
EP (1) EP1856104A1 (es)
JP (1) JP2008528618A (es)
KR (1) KR20070103744A (es)
CN (1) CN101111491A (es)
AR (1) AR053437A1 (es)
AU (1) AU2006208021A1 (es)
BR (1) BRPI0606871A2 (es)
CA (1) CA2595376A1 (es)
CR (1) CR9215A (es)
GT (1) GT200600032A (es)
HN (1) HN2006003347A (es)
IL (1) IL183712A0 (es)
MX (1) MX2007008952A (es)
NI (1) NI200700188A (es)
NO (1) NO20072879L (es)
PE (1) PE20061200A1 (es)
RU (1) RU2007121255A (es)
TW (1) TW200637850A (es)
WO (1) WO2006081455A1 (es)
ZA (1) ZA200706203B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070185186A1 (en) * 2006-02-03 2007-08-09 Wyeth Compositions for the delivery of substituted napthyl indole derivatives and methods of their use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903206A1 (en) 1989-09-07 1991-03-13 Abbott Lab Indole-, benzofuran-, and benzothiophene-containing¹lipoxygenase-inhibiting compounds
US5151435A (en) 1991-04-08 1992-09-29 Merck & Co., Inc. Angiotensin ii antagonists incorporating an indole or dihydroindole
IL101785A0 (en) 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL109568A0 (en) 1993-05-19 1994-08-26 Fujisawa Pharmaceutical Co Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
CA2134192A1 (en) 1993-11-12 1995-05-13 Michael L. Denney 5, 6-bicyclic glycoprotein iib/iiia antagonists
US5552412A (en) 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
NZ318228A (en) 1995-09-01 1999-07-29 Lilly Co Eli Indolyl neuropeptide y receptor antagonists
CA2264020A1 (en) 1996-08-26 1998-03-05 Jean Bemis Inhibitors of phospholipase enzymes
US6703527B2 (en) * 2001-05-24 2004-03-09 Nikken Chemicals Co., Ltd. Method for oxidation of allyl alcohol
TWI224101B (en) * 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
TW591020B (en) 2001-06-20 2004-06-11 Wyeth Corp 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)

Also Published As

Publication number Publication date
RU2007121255A (ru) 2009-03-10
CR9215A (es) 2007-11-23
BRPI0606871A2 (pt) 2009-07-21
NI200700188A (es) 2008-05-09
NO20072879L (no) 2007-06-26
JP2008528618A (ja) 2008-07-31
TW200637850A (en) 2006-11-01
US7323483B2 (en) 2008-01-29
ZA200706203B (en) 2009-12-30
KR20070103744A (ko) 2007-10-24
CA2595376A1 (en) 2006-08-03
HN2006003347A (es) 2011-03-30
WO2006081455A1 (en) 2006-08-03
IL183712A0 (en) 2007-09-20
AU2006208021A1 (en) 2006-08-03
MX2007008952A (es) 2007-09-18
US20080071091A1 (en) 2008-03-20
EP1856104A1 (en) 2007-11-21
US20060183917A1 (en) 2006-08-17
PE20061200A1 (es) 2006-12-19
CN101111491A (zh) 2008-01-23
AR053437A1 (es) 2007-05-09

Similar Documents

Publication Publication Date Title
GT200600174A (es) Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
GT200800258A (es) Compuestos de pirrolo-pirimidina y sus usos
GT200600306A (es) Inhibidores de glutamato agrecanasa
GT200600134A (es) Compuestos novedosos de derivados de aminosulfonilo
CR9832A (es) Compuestos de pirimidina amida como inhibidores de pgds
PA8783501A1 (es) Derivados de quinaxolina como inhibidores de la actividad de cinasa de tirosina de las cinasas janus
GT200500218A (es) Derivados de triazolopiridinilsulfanilo como inhibidores de quinasa map p38
GT200500242A (es) Procesos para la preparaciòn de 2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolinas sustituidas
DOP2007000051A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevención de diabetes
ECSP10010599A (es) Derivados de tienopiridonas como activadores de proteina quinasa activados por amp (ampk)
ECSP088638A (es) Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores de gamma secretasa relacionados
GT200600444A (es) Compuestos anti-hipercolesterolemicos
GT200600197A (es) Compuestos y composiciones como inhibidores de proteina quinasa
NO20076502L (no) Pyrrolopyridiner nyttige som inhibitorer av proteinkinase
CO6321248A2 (es) Derivados de triazol utiles para el tratamiento de enfermedades
GT200800170A (es) Compuestos de n-formil-hidroxilamina
UY30352A1 (es) Nuevas prolinamidas sustituidas, composiciones conteniéndolas, procesos de preparacion y aplicaciones
UY29927A1 (es) Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones
CO6450621A2 (es) Sulfonamidas nematocidas
AR055613A1 (es) Formas cristalinas delta y epsilon de mesilato de imatinib
CR11370A (es) Inhibidores de quinasas simil polo
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
GT200300033A (es) Derivados de nicotinamida utiles como inhibidores de pde4
EA200901124A1 (ru) Соединения формулы (i) в качестве ингибиторов серинпротеазы